Filing Details
- Accession Number:
- 0001181431-12-037981
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-06-26 16:09:01
- Reporting Period:
- 2012-06-22
- Filing Date:
- 2012-06-26
- Accepted Time:
- 2012-06-26 16:09:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1429260 | Coronado Biosciences Inc | CNDO | Pharmaceutical Preparations (2834) | 205157386 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1046351 | Md L Glenn Cooper | C/O Coronado Biosciences, Inc. 15 New England Executive Park Burlington MA 01803 | See Remarks | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 | Acquisiton | 2012-06-22 | 10,000 | $5.30 | 40,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Represents the weighted average purchase price for the reported transactions. The range of prices for such transactions was $5.2916 to $5.306. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- Includes shares of common stock issued on November 15, 2011 pursuant to the automatic conversion of preferred stock held by the reporting person.
Billionaire Hedge Funds
